Proteolytically Active Allergens Cause Barrier Breakdown  by Roelandt, Truus et al.
commentary See related article on pg 1930
1878 Journal of Investigative Dermatology (2008), Volume 128 © 2008 The Society for Investigative Dermatology
Proteolytically Active Allergens 
Cause Barrier Breakdown
Truus Roelandt1, Carol Heughebaert1 and Jean-Pierre Hachem1
Two major allergens—the house dust mite Dermatophagoides pteronyssinus 
(Der p 1) and cockroach allergens—are proteolytically active and stimulate the 
protease-activated receptor 2 (PAR-2). Jeong et al. (2008, this issue) exposed 
mouse and human epidermis to both allergens and correlated the observed 
delay in permeability barrier recovery to PAR-2 activation/signaling. This article 
exposes the secretive boundaries between barrier homeostasis and immunity.
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The pathogenesis of atopic dermatitis 
(AD) has generally been considered 
to be immunity-driven, assuming 
an immunologic basis of AD (i.e., 
T helper 1/T helper 2 imbalance and 
IgE overproduction/receptor abnormal-
ities: the “inside–outside” paradigm for 
the pathogenesis of inflammatory der-
matoses). Although AD does not follow 
a pure mendelian mode of inheritance, 
data from monozygotic and dizygotic 
twins indicate a strong genetic back-
ground among AD patients. Hence, 
a major breakthrough in the genetics 
of AD has brought to light the impor-
tance of epidermal barrier abnormali-
ties in AD pathogenesis. Several loss-
of-function variants in the gene encod-
ing filaggrin (FLG) have been shown 
to cause ichthyosis vulgaris, but the 
R510X and 2282del4 variants are also 
strong predisposing factors for AD 
(Palmer et al., 2006).
Pro-filaggrin (pro-flg) localized 
with in keratohyalin granules is pro-
cessed into flg, an intermediate fila-
ment-associated protein that aids in 
the aggregation of keratin during ter-
minal differentiation of keratinocytes 
at the transition between the stratum 
corneum (SC) and the stratum granu-
losum (SG). Consequently, flg plays a 
key role in the formation of SC corneo-
cytes and in the structure of the corni-
fied envelope. Abnormalities in either 
the synthesis or the processing of flg 
could strongly affect the epidermal 
barrier and may explain the pathogen-
ic implications of permeability barrier 
abnormities in the onset of AD (Elias 
and Steinhoff, 2008). On the basis of 
this concept of a pathogenetic role 
for the epidermal barrier, evidence 
demonstrates that the SC is a biosen-
sor that regulates epidermal lipid and 
DNA-metabolic responses to a variety 
of exogenous insults through initiation 
of a signaling cascade (i.e., changes in 
levels of epidermal cytokines). Such 
signaling molecules, released after 
injury to the SC, initiate a cytokine 
cascade that could induce inflamma-
tion (the outside–inside paradigm).
Importantly, house dust mites and 
cockroach allergens play a dual role 
in the onset of AD. First, they con-
stitute the most common sources of 
allergens associated with atopic mani-
festations such as asthma, rhinitis, and 
AD. Moreover, these allergens directly 
affect the structure and function of the 
epidermal barrier (as demonstrated in 
the study by Jeong et al., 2008, this 
issue). Allergens derived from house 
dust mites are divided into two groups 
(1 and 2) based on the incidence of 
sensitized patients, amount of specific 
IgE, and content of mite extract. Der 
p 1 belongs to group 1 and exhibits 
cysteine protease activity, which in turn 
is involved in its pathoallergenicity by 
facilitating the transepithelial ingress 
of allergens, cleaving, or interact-
ing with cell surface molecules (i.e., 
PAR-2) and modulating cell functions. 
Mice immunized with three forms of 
active recombinant (r)Der p 1 pro-
duced higher total serum IgE levels 
compared with mice immunized with 
enzymatically inactive rDer p 1, sug-
gesting that the proteolytic activity 
of the cysteine protease contributes 
significantly to the process of sensiti-
zation (Kikuchi et al., 2006). Unlike 
Der p 1, Bla g 2, the potent cockroach 
allergen, exhibits an aspartic protease-
like structural sequence homology but 
contains a critical amino acid substi-
tution that restrains proteolytic activ-
ity (Pomes et al., 2002). Residual 
proteolytic activity has been found for 
Bla g 2, but it does not seem to con-
tribute to its allergenicity (Pomes et al., 
2002). However, Jeong et al. (2008) 
demonstrate that complete cockroach 
extract maintains a proteolytic profile 
that is capable of activating PAR-2 in 
keratinocytes, in accordance with pre-
vious findings in lung fibroblasts and 
human airway epithelial cells (Kondo 
et al., 2004).
Several types of proteases and their 
inhibitors exist in both murine and 
human SC. Epidermal serine proteases 
(SPs) from the kallikrein (klk) family 
regulate SC integrity/cohesion and skin 
barrier homeostasis in a pH-dependent 
manner (Hachem et al., 2003). In addi-
tion to the fact that klks regulate SC 
desquamation by corneodesmolysis, 
klks operate in a protealytic cascade 
that contributes to (i) the proinflam-
matory responses (klk7-dependent 
proteolytic activation of pro-IL-β), 
(ii) lamellar body (LB) secretion 
(PAR-2 stimulation (Hachem et al., 
2006a)), and (iii) the production of 
newly formed corneocytes (PAR-2 and 
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caspase-14 activation (Demerjian 
et al., 2008)). Among the protease 
inhibitors, three—i.e., the secretory 
leukocyte protease inhibitor, elafin, 
plasminogen activator inhibitor type 
2—are cross-linked to the corni-
fied envelope, and a fourth, cystatin, 
has been reported to be linked to the 
cornified envelope or secreted by LB. 
A fifth serine protease inhibitor, the 
SPINK 5 gene product LEKTI, is pres-
ent in the SC and contributes large-
ly to regulation of the klk cascade. 
Mutations in the SPINK 5 genes cause 
Netherton’s syndrome, characterized 
by a profound barrier abnormality, loss 
of SC (i.e., decreased SC integrity and 
cohesion), inflammation, and atopic 
manifestations (Hachem et al., 2006b). 
Unopposed SP activity resulting from 
LEKTI deficiency in Netherton’s syn-
drome illustrates the importance of 
serine protease inhibitors in regulating 
proteolytic activity in the epidermis 
(Hachem et al., 2006b). Besides FLG 
mutations, a single-nucleotide poly-
morphism in SPINK5, possibly leading 
to reduced LEKTI expression or func-
tion, was found to be associated with 
AD. A potential gain-of-function poly-
morphism in klk7 was also linked to 
AD, which in turn could contribute to 
an endogenous increase in SC prote-
olytic defects in AD patients. Together 
with FLG mutations, both LEKTI and 
klk7 single-nucleotide polymorphisms 
could affect barrier function, leading 
to disease manifestations. Additional 
SP imbalance caused by allergens with 
a proteolytic profile, such as Der p 1 
or cockroach proteases, may accentu-
ate endogenous barrier abnormalities, 
increasing both epidermal damage and 
underlying (pro)inflammatory respons-
es. Atopic manifestations could there-
fore be produced both endogenously 
(multi-hit genetic defects) and exoge-
nously (allergens, environmental stress, 
etc.), secondarily leading to abnormal-
ities in immune responses.
Par-2 mediates SP negative effects
Two types of PARs have been identified 
in the epidermis as likely contributors 
to SP downstream signaling: PAR-1 
and PAR-2. They are characterized by 
a unique mechanism of activation. 
Rather than being activated by simple 
ligand occupancy, they are activated 
enzymatically through proteolytic 
cleavage of the receptor. Thrombin—
and to a lesser degree trypsin (both 
SPs)—has been described as an acti-
vator of PAR-1. PAR-2 is nonsensi-
tive to thrombin, but it can be acti-
vated by trypsin and in the epidermis 
by klk5 and 14. The high levels of 
PAR-2 expression in the SG implicate 
this receptor as a potential sensor to 
SP activity and could therefore con-
tribute to cellular response through 
G-coupled protein operative pathways 
(Hachem et al., 2006a). Thus, place-
ment of PARs in the plasma mem-
brane of cells enables them to detect 
extracellularly active SP that might be 
involved in epidermal differentiation, 
defense mechanisms, and permeabil-
ity barrier homeostasis. PAR-2 activa-
tion in the skin has been suggested to 
be involved in the elicitation of itch 
and was found to be highly expressed 
in lesional skin of AD patients. PAR-2 
induces edema, plasma extravasation, 
leukocyte recruitment, upregulation of 
cell adhesion molecules, and release 
of proinflammatory cytokines in the 
early phases of both toxic and aller-
gic contact dermatitis. Consequently, 
PAR-2 activation by either Der p 1 or 
cockroach proteases could contrib-
ute to the proinflammatory response 
of epidermal keratinocytes. In addi-
tion, Jeong et al. (2008) demonstrate 
that topical application of cockroach 
allergens delays LB secretion and 
permeability barrier recovery after 
acute barrier disruption in accordance 
with our recently published data show-
ing that PAR-2 activation using SLIGRL 
(PAR-2 agonist peptide) abolishes LB 
secretion (Hachem et al., 2006a). PAR-
2-mediated damaging effects to epi-
dermal structure and function could 
thus be explained by both the nega-
tive effects on permeability barrier 
homeostasis and the contribution to 
dermoepidermal inflammation.
Figure 1. Protease-activated receptor 2 (Par-2) activation signals terminal differentiation and 
prevents epidermal hyperplasia. (a) Terminal differentiation was assessed in hairless mice prior to (basal) 
and 3 hours following tape stripping (TS)-induced barrier abrogation, using TUNEL staining as described 
in the text. Immediately following TS, we applied either SLIGRL (PAR-2 agonist peptide;  
100 mM in propylene glycol:ethanol; 7:3) or ILSGRL (scrambled control peptide; 100 mM in propylene 
glycol:ethanol, 7:3). Compared with baseline and ILSGRL treatment, PAR-2 activation by SLIGRL 
significantly amplified the TS-induced wave of cornification (i.e., increased TUNEL staining at the 
stratum corneum–stratum granulosum interface). (b) Epidermal proliferation, assessed as the number of 
proliferating cell nuclear antigen (PCNA)-positive cells, was significantly increased in PAR-2 knockout 
(KO) mice compared with wild-type (WT) littermates. (c, d) Epidermal hyperplasia was experimentally 
induced in PAR-2 KO and WT littermate mice by twice-daily TS of the stratum corneum for  
4 consecutive days. Epidermal thickness was significantly increased in PAR-2 KO animals compared 
with WT mice. Results are given as means ±SEM. Magnification bar, 10 µm.
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PAR-2-deficient mice exhibit a 
significantly increased number of 
chemically induced tumors, suggest-
ing a tumor-protective role for PAR-2 
(Rattenholl et al., 2007). Following 
barrier abrogation, a decrease in cor-
neocyte formation—assessed by the 
number of TdT-mediated dUTP nick-
end-labeling (TUNEL, Fluorescein-
FragEL, Calbiochem, Merck Chemicals, 
Leuven, Belgium)-positive cells at 
the SG–SC interface—was found in 
PAR-2 knockout animals, suggesting 
a delay in terminal differentiation of 
the uppermost SG cells (Demerjian 
et al., 2008). As illustrated in Figure 
1a, application of SLIGRL to hairless 
mouse skin following tape stripping–
induced barrier abrogation increased 
the number of TUNEL-positive cells 
compared with control peptide and to 
basal levels (prior to tape stripping). 
In addition, the absence of PAR-2 in 
knockout mice (i) increased epidermal 
proliferation following tape stripping, 
demonstrated by an increased num-
ber of proliferating cell nuclear anti-
gen–positive cells (PCNA assay from 
Calbiochem; Figure 1b) and (ii) sensi-
tized murine epidermis to the devel-
opment of epidermal hyperplasia (i.e., 
increased epidermal thickness; Figure 
1c,d), induced by repeated barrier 
abrogation by tape stripping. Together, 
these data demonstrate that PAR-2 
activation contributes to the terminal 
differentiation of epidermal keratino-
cytes and that the absence of PAR-2 
increases the propensity of experi-
mentally induced hyperproliferation 
and tumorigenesis. Besides partici-
pating in proinflammatory responses 
and LB secretion, PAR-2 acts as a sen-
tinel to detect SP activity consequent 
or parallel to the loss of corneocytes 
and barrier damage. The strategic 
location of PAR-2 at the plasma mem-
brane of the uppermost SG, most spe-
cifically within the lipid rafts signaling 
domains, allows the receptor to detect 
the SP-mediated loss of SC cells and, 
as a result, induce a wave of cornifica-
tion leading to SC replenishment with 
newly formed corneocytes (Figure 2).
The article by Jeong et al. (2008) pro-
vides new insights into the pathogenesis 
and—potentially—the treatment of AD. 
The dual effect (allergenicity, proteolyt-
ic activity/signaling) of house dust mite 
and cockroach allergens clearly brings 
together defects in the epidermal barrier 
with stimulation of the immune system 
caused by these potent environmental 
allergens. Further study of the possible 
role of both endogenous and exog-
enous proteases in permeability bar-
rier dysfunction is key to understanding 
epidermal barrier dysregulation in the 
atopic diseases.
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Figure 2. Sentinel role of protease-activated receptor 2 (Par-2) in permeability barrier homeostasis, stratum 
corneum (Sc) formation, and (pro)inflammatory responses. LB, lamellar body; SG, stratum granulosum.
